Order Article Reprints

Thomssen C, Vetter M, Kantelhardt EJ, Meisner C, Schmidt M, Martin PM, Clatot F, Augustin D, Hanf V, Paepke D, et al. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers. 2023; 15(5):1580. https://doi.org/10.3390/cancers15051580

Thomssen, Christoph, Martina Vetter, Eva J. Kantelhardt, Christoph Meisner, Marcus Schmidt, Pierre M. Martin, Florian Clatot, Doris Augustin, Volker Hanf, Daniela Paepke, and et al. 2023. "Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group" Cancers 15, no. 5: 1580. https://doi.org/10.3390/cancers15051580

Thomssen, C., Vetter, M., Kantelhardt, E. J., Meisner, C., Schmidt, M., Martin, P. M., Clatot, F., Augustin, D., Hanf, V., Paepke, D., Meinerz, W., Hoffmann, G., Wiest, W., Sweep, F. C. G. J., Schmitt, M., Jänicke, F., Loibl, S., Minckwitz, G. v., & Harbeck, N., on behalf of the NNBC 3-Europe Study Group. (2023). Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers, 15(5), 1580. https://doi.org/10.3390/cancers15051580